# BioNTech (BNTX) — Analyst Forecast

BNTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bntx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 14 | 9 | 0 | 23 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $105.00 | $121.20 | $132.00 | 5 |

Last price $90.20 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 14, 2026 | Canaccord Genuity | Maintained | Buy | $132.00 |
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | $114.00 |
| Sep 8, 2026 | BMO Capital | Downgraded | Outperform → Market Perform | $105.00 |
| Aug 31, 2026 | Canaccord Genuity | Maintained | Buy | $136.00 |
| Aug 5, 2026 | Evercore ISI Group | Maintained | Outperform | $130.00 |
| Aug 5, 2026 | Citigroup | Maintained | Buy | $125.00 |
| Jul 8, 2026 | Morgan Stanley | Maintained | Overweight | $119.00 |
| May 27, 2026 | UBS | Upgraded | Neutral → Buy | $135.00 |
| May 22, 2026 | Bernstein | Initiated Coverage | Market Perform | $96.00 |
| May 6, 2026 | Wells Fargo | Maintained | Overweight | $140.00 |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | $158.00 |
| Apr 27, 2026 | HC Wainwright & Co. | Maintained | Buy | $130.00 |
| Apr 10, 2026 | Morgan Stanley | Maintained | Overweight | $126.00 |
| Mar 31, 2026 | HC Wainwright & Co. | Maintained | Buy | $130.00 |
| Mar 11, 2026 | BMO Capital | Maintained | Outperform | $128.00 |
| Mar 11, 2026 | Citigroup | Maintained | Buy | $130.00 |
| Mar 11, 2026 | Canaccord Genuity | Maintained | Buy | $171.00 |
| Mar 11, 2026 | Morgan Stanley | Maintained | Overweight | $125.00 |
| Mar 11, 2026 | TD Cowen | Maintained | Hold | $94.00 |
| Mar 10, 2026 | Jefferies | Maintained | Buy | $138.00 |

## Frequently Asked Questions

### What is the price target for BNTX stock?

The average 12-month analyst price target for BioNTech (BNTX) is $121.20, with a high estimate of $132.00 and a low of $105.00, across 5 analysts.

### Is BNTX a buy, sell, or hold?

Analysts covering BioNTech currently average a Buy rating: 14 buy, 9 hold and 0 sell, from 23 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for BNTX?

The average price target of $121.20 implies 34.37% upside from the last price of $90.20.

### What is the latest analyst rating on BNTX?

On Oct 14, 2026, Canaccord Genuity maintained BioNTech at Buy with a price target of $132.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).